Primary Amoebic Meningoencephalitis with Progression to Brain Death Following Naegleria Fowleri Infection in a Teenage Female

Abstract

Naegleria fowleri is a high-temperature freshwater-living amoeba that causes primary amoebic meningoencephalitis (PAM) by invading nasal epithelium. N. fowleri lives ubiquitously in high-temperature freshwater, but only around 400 cases of PAM have been published worldwide. The mortality rate is 98%. No treatment is 100% effective. A previously healthy 17-year-old female presented to an urgent care center with fever, headache, sore throat, ear pain, and dizziness. She had swum in freshwater 5 days prior. Her symptoms progressed to altered mental status, photo- and phonophobia, and neck stiffness. Within 4 days, she developed increased intracranial pressure (ICP) and eventually brain death. Two unsuccessful lumbar punctures were attempted before the third provided cerebrospinal fluid (CSF) for polymerase chain reaction (PCR) analysis. Magnetic resonance imaging showed diffuse cerebral edema, effacement of basal cisterns, tonsillar herniation with diffuse loss of gray–white matter differentiation, leptomeningitis, bifrontal encephalitis with evolving frontal lobe cortical infarcts, and ventriculitis. She was treated with metronidazole, vancomycin, ceftriaxone, acyclovir, and doxycycline. Her increased ICP progressed to brain death, and she died 11 days after lake exposure. CSF PCR was reported positive for N. fowleri the day after her death. Despite advances in diagnostic testing for N. fowleri with PCR, mortality rate is high and current treatments are highly ineffective. This case highlights the importance of epidemiological exposure and considering PAM on the differential diagnosis. Although headache and fever are benign symptoms, they could also represent the first stages of a deadly disease and their progression should be addressed promptly.

Keywords

primary amoebic meningoencephalitis - Naegleria fowleri - sinusitis - headache

Authors' Contributions

S.B. analyzed and reported patient data regarding the acute disease process and was the main contributor to writing the manuscript. I.C. and R.M. participated in a direct care of the patient and assisted with revising the manuscript. All authors read and approved the final manuscript. S.S. provided the images extracted from CT and MRI studies performed on this patient. S.S. also provided the details on the radiology report on the identification of anatomical structures and abnormal findings. H.S. provided the image from the clinical pathology report.

Informed Consent

Consent was obtained from the patient's mother. A generic consent form was utilized and is available upon request.

Availability of Data and Materials

Data supporting the results reported in this article can be found using the reference list at the end of this manuscript. All data were obtained from online access to journals, websites, and textbooks.

Publication History

Received: 11 November 2023

Accepted: 27 April 2024

Article published online:
30 May 2024

• References

• 1 Ahmad Zamzuri MI, Abd Majid FN, Mihat M. et al. Systematic review of brain-eating amoeba: a decade update. Int J Environ Res Public Health 2023; 20 (04) 3021
• 2 Shakoor S, Beg MA, Mahmood SF. et al. Primary amebic meningoencephalitis caused by Naegleria fowleri, Karachi, Pakistan. Emerg Infect Dis 2011; 17 (02) 258-261
• 3 Andrade RM, Reed SL. Amebiasis and infection with free-living amebae. In: Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J. eds. Harrison's Principles of Internal Medicine, 20e. McGraw-Hill Education; 2018. Accessed August 25, 2023 at: accessmedicine.mhmedical.com/content.aspx?aid=1160014526
• 4 Güémez A, García E. Primary amoebic meningoencephalitis by Naegleria fowleri: pathogenesis and treatments. Biomolecules 2021; 11 (09) 1320
• 5 Gharpure R, Bliton J, Goodman A, Ali IKM, Yoder J, Cope JR. Epidemiology and clinical characteristics of primary amebic meningoencephalitis caused by Naegleria fowleri: a global review. Clin Infect Dis 2021; 73 (01) e19-e27
• 6 Naegleria fowleri—Primary amebic meningoencephalitis (PAM)—amebic encephalitis | CDC. Centers for Disease Control and Prevention. Published May 3, 2023. Accessed December 28, 2023 at: https://www.cdc.gov/parasites/naegleria/index.html
• 7 Martinez AJ. Free-living amebas: Naegleria, Acanthamoeba and Balamuthia. In: Baron S. ed. Medical Microbiology. 4th ed.. University of Texas Medical Branch at Galveston; 1996. Accessed December 28, 2023 at: http://www.ncbi.nlm.nih.gov/books/NBK7960/
• 8 Siddiqui R, Ali IKM, Cope JR, Khan NA. Biology and pathogenesis of Naegleria fowleri . Acta Trop 2016; 164: 375-394
• 9 Primary Amebic Meningoencephalitis—Georgia. 2002. Morbidity and mortality weekly report. Published October 10, 2003. Accessed September 1, 2023 at: https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5240a4.htm
• 10 Singh P, Kochhar R, Vashishta RK. et al. Amebic meningoencephalitis: spectrum of imaging findings. AJNR Am J Neuroradiol 2006; 27 (06) 1217-1221
• 11 Onofri A, Pensato U, Rosignoli C. et al; European Headache Federation School of Advanced Studies (EHF-SAS). Primary headache epidemiology in children and adolescents: a systematic review and meta-analysis. J Headache Pain 2023; 24 (01) 8
• 12 Colon BL, Rice CA, Guy RK, Kyle DE. Phenotypic screens reveal posaconazole as a rapidly acting amebicidal combination partner for treatment of primary amoebic meningoencephalitis. J Infect Dis 2019; 219 (07) 1095-1103
• 13 Rizo-Liendo A, Sifaoui I, Arberas-Jiménez I, Reyes-Batlle M, Piñero JE, Lorenzo-Morales J. Fluvastatin and atorvastatin induce programmed cell death in the brain eating amoeba Naegleria fowleri . Biomed Pharmacother 2020; 130: 110583